Comsentimento

BrazilHealthtech

Comsentimento is a Brazilian healthtech startup that uses artificial intelligence and data analysis to improve cancer treatment. The company received a R$1.5 million pre-seed investment led by Incubate Fund, a Japanese early-stage fund that entered Brazil in 2021. The startup aims to revolutionize cancer care through its AI-driven platform. No further details on its product, customers, or business model are available from the provided evidence.